|
MKI67IP expression based on
|
Statistics: Unpaired two sample T-test was employed to evaluate levels of significance in expression level between any two sample groups
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.702500E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.722100E-03 |
| Normal-vs-Stage2 |
7.995800E-01 |
| Normal-vs-Stage3 |
8.864200E-02 |
| Normal-vs-Stage4 |
4.984400E-02 |
| Stage1-vs-Stage2 |
4.764000E-02 |
| Stage1-vs-Stage3 |
5.562600E-01 |
| Stage1-vs-Stage4 |
8.130800E-01 |
| Stage2-vs-Stage3 |
1.703600E-01 |
| Stage2-vs-Stage4 |
1.379390E-01 |
| Stage3-vs-Stage4 |
7.777800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.159300E-03 |
| Normal-vs-AfricanAmerican |
4.644000E-01 |
| Normal-vs-Asian |
5.236100E-03 |
| Caucasian-vs-AfricanAmerican |
6.076400E-01 |
| Caucasian-vs-Asian |
4.042400E-01 |
| AfricanAmerican-vs-Asian |
3.038600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.871600E-02 |
| Normal-vs-Female |
7.398600E-03 |
| Male-vs-Female |
7.360000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.583530E-03 |
| Normal-vs-Age(41-60Yrs) |
5.723800E-02 |
| Normal-vs-Age(61-80Yrs) |
4.240000E-01 |
| Normal-vs-Age(81-100Yrs) |
3.391200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.695160E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.561900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.616000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.066800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.193600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.272000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.243600E-01 |
| Classical-VS-Follicular |
5.07450004239018E-09 |
| Classical-VS-Other |
9.496800E-01 |
| Classical-VS-Normal |
1.72944999999869E-05 |
| Tall-VS-Follicular |
1.099620E-03 |
| Tall-VS-Other |
9.137400E-01 |
| Tall-VS-Normal |
5.278100E-02 |
| Follicular-VS-Other |
5.620200E-02 |
| Follicular-VS-Normal |
1.827940E-02 |
| Other-VS-Normal |
3.986400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.017200E-01 |
| Normal-vs-N1 |
1.150390E-01 |
| N0-vs-N1 |
3.446000E-01 |
|
|
